KM Research Hub
← 返回论文库
无 KM 图 入排:待复核 图源:开放图源暂不可得 入排置信度 0.45

Dose de-escalation of elective neck irradiation in head and neck cancer: A secondary analysis of acute toxicity findings from the randomized controlled UPGRADE-RT trial.

Sven van den Bosch, Maurice C Cox, Patricia A H Doornaert, Frank J P Hoebers, Bas Kreike, Marije R Vergeer, Ellen M Zwijnenburg, Gerjon Hannink, Tim Dijkema, Johannes H A M Kaanders, Dutch Head and Neck Society

Radiother Oncol 213 111196

PMID41057084
PMCID-
DOI10.1016/j.radonc.2025.111196
发表日期2025-10-07
入排依据:The record is a secondary analysis of a Phase III randomized trial in head and neck cancer, but it reports only acute toxicity endpoints (dysphagia, mucositis), not the required survival, progression, recurrence, death, or time-to-event efficacy outcomes. Therefore, eligibility cannot be established.
PubMed 未展示 Figure,且无可用 PMC 全文;如需图片,需要从出版社页面获取。
摘要

摘要

BACKGROUND: The multicenter, randomized UPGRADE-RT trial (NCT02442375) evaluated the safety and clinical benefit of elective neck radiotherapy with reduced versus standard dose in head and neck squamous cell carcinoma (SCC). This is a secondary analysis of acute toxicity. METHODS: Three hundred patients with cT2-4 N0-2 M0 SCC of the oropharynx, larynx or hypopharynx received definitive accelerated radiotherapy alone (34 fractions of 2 Gy in 5.5 weeks). Dose for elective neck irradiation was randomly assigned (ratio 2:1 to dose reduction, 43 Gy versus control, 50 Gy). Radiation induced acute toxicity was scored according to the CTC v2.0 until 90 days after start of radiotherapy. RESULTS: The analysis included 295 evaluable patients (dose reduction, 196 and control, 99). Dysphagia grade ≥ 3 (requiring tube feeding) occurred significantly less in the dose reduction group compared to controls (RR, 0.56, [95 % CI, 0.32 to 0.98], p = 0.046). A mean dose ≥ 45 Gy to the pharyngeal mucosal epithelium was associated with increased rates of mucositis grade ≥ 3 (RR, 1.41, [95 % CI, 1.17 to 1.70], p < 0.001) and dysphagia grade ≥ 3 requiring tube feeding (RR, 3.61, [95 % CI, 1.72 to 7.57], p < 0.001). Less patients in the dose reduction group had a pharyngeal mucosal epithelium mean dose ≥ 45 Gy (RR, 0.80, [95 % CI, 0.65 to 0.99], p = 0.041). CONCLUSION: Reduced elective dose resulted in significantly more patients with a pharyngeal mucosal epithelium mean dose below 45 Gy. This was associated with a reduced rate of grade ≥ 3 pharyngeal mucositis and a lower rate of acute dysphagia grade ≥ 3 (requiring tube feeding).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。